CoChat

Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes

Open access
Tamási, Viola, Petschner, Peter, Adori, Csaba, Kirilly, Eszter, Ando, Romeo D., Tothfalusi, Laszlo, Juhasz, Gabriella, Bagdy, Gyorgy · 2014 · PLoS ONE
Cited by 61

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Venlafaxine (VLX), a serotonine-noradrenaline reuptake inhibitor, is one of the most commonly used antidepressant drugs in clinical practice for the treatment of major depressive disorder (MDD). Despite being more potent than its predecessors, similarly to them, the therapeutical effect of VLX is visible only 3-4 weeks after the beginning of treatment. Furthermore, recent papers show that antidepressants, including also VLX, enhance the motor recovery after stroke even in non depressed persons. In the present, transcriptomic-based study we looked for changes in gene expressions after a long-term VLX administration. METHODS: Osmotic minipumps were implanted subcutaneously into Dark Agouti rats providing a continuous (40 mg/kg/day) VLX delivery for three weeks. Frontal regions of the cerebral cortex were isolated and analyzed using Illumina bead arrays to detect genes showing significant chances in expression. Gene set enrichment analysis was performed to identify specific regulatory networks significantly affected by long term VLX treatment. RESULTS: Chronic VLX administration may have an effect on neurotransmitter release via the regulation of genes involved in vesicular exocytosis and receptor endocytosis (such as Kif proteins, Myo5a, Sv2b, Syn2 or Synj2). Simultaneously, VLX activated the expression of genes involved in neurotrophic signaling (Ntrk2, Ntrk3), glutamatergic transmission (Gria3, Grin2b and Grin2a), neuroplasticity (Camk2g/b, Cd47), synaptogenesis (Epha5a, Gad2) and cognitive processes (Clstn2). Interestingly, VLX increased the expression of genes involved in mitochondrial antioxidant activity (Bcl2 and Prdx1). Additionally, VLX administration also modulated genes related to insulin signaling pathway (Negr1, Ppp3r1, Slc2a4 and Enpp1), a mechanism that has recently been linked to neuroprotection, learning and memory. CONCLUSIONS: Our results strongly suggest that chronic VLX treatment improves functional reorganization and brain plasticity by influencing gene expression in regulatory networks of motor cortical areas. These results are consonant with the synaptic (network) hypothesis of depression and antidepressant-induced motor recovery after stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0113662

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 85

  1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing. · DOI · Paper page
  2. EJ Nestler, 2002, Neurobiology of depression, Neuron, 34(1), 13, 10.1016/S0896-6273(02)00653-0 · DOI · Paper page
  3. HU Wittchen, 2012, The burden of mood disorders, Science 338, (6103), 15, 10.1126/science.1230817 · DOI · Paper page
  4. G Juhasz, 2014, Brain galanin system genes interact with life stresses in depression-related phenotypes, Proc Natl Acad Sci U S A, 111(16), E1666, 10.1073/pnas.1403649111 · DOI · Paper page
  5. D Smith, 2002, Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis, Br J Psychiatry May, 180, 396, 10.1192/bjp.180.5.396 · DOI · Paper page
  6. M Gex-Fabry, 2004, Time course of clinical response to venlafaxine: relevance of plasma level and chirality, Eur J Clin Pharmacol Feb, 59(12), 883, 10.1007/s00228-003-0710-3 · DOI
  7. JJ Yu, 2013, Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signalling pathway. Psychopharmacology (Berl), 225(2), 361
  8. C Diener, 2012, A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression, Neuroimage 2, 61(3), 677, 10.1016/j.neuroimage.2012.04.005 · DOI · Paper page
  9. A Kumar, 2000, Volumetric asymmetries in late-onset mood disorders: an attenuation of frontal asymmetry with depression severity, Psychiatry Research, 100, 41, 10.1016/S0925-4927(00)00067-6 · DOI
  10. R Bakshi, 2000, Brain MRI lesions and atrophy are related to depression in multiple sclerosis,, Neuro Report, 11(6, 1153
  11. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, et al.. (2012) Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Systematic Reviews Issue 11. Art. No.: CD009286. · DOI · Paper page
  12. CY Li, 2014, The effects of venlafaxine on cortical motor area activity in healthy subjects: a pilot study, J Clin Psychopharmacol Feb, 34(1), 93
  13. Paxinos G, Watson C (1986)The rat brain in stereotaxic coordinates, 2nd edn. Sydney; Orlando: Academic Press.
  14. P Petschner, 2013, Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats, BMC Genomics, 1, 930, 10.1186/1471-2164-14-930 · DOI
  15. MJ Dunning, 2007, Beadarray: R classes and methods for Illumina bead-based data, Bioinformatics, 16, 2183, 10.1093/bioinformatics/btm311 · DOI · Paper page
  16. RD Pearson, 2009, puma: a Bioconductor package for propagating uncertainty in microarray analysis, BMC Bioinformatics, 10, 211, 10.1186/1471-2105-10-211 · DOI
  17. RC Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biology, 5(10), R80, 10.1186/gb-2004-5-10-r80 · DOI · Paper page
  18. A Alttoa, 2010, Differential gene expression in a rat model of depression based on persistent differences in exploratory activity, European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 20(5), 288, 10.1016/j.euroneuro.2009.09.005 · DOI
  19. AI Saeed, 2006, TM4 microarray software suite, Methods in enzymology, 411, 134, 10.1016/S0076-6879(06)11009-5 · DOI · Paper page
  20. AI Saeed, 2003, TM4: a free, open-source system for microarray data management and analysis, BioTechniques, 34(2), 374, 10.2144/03342mt01 · DOI · Paper page
  21. MB Eisen, 1998, Cluster analysis and display of genome-wide expression patterns, Proc Natl Acad Sci USA, 95(25), 14863, 10.1073/pnas.95.25.14863 · DOI · Paper page
  22. M Schäfer, 2005, Neurotractin/kilon promotes neurite outgrowth and is expressed on reactive astrocytes after entorhinal cortex lesion, Mol Cell Neurosci, 29(4), 580, 10.1016/j.mcn.2005.04.010 · DOI · Paper page
  23. TA Smitherman, 2011, The use of antidepressants for headache prophylaxis, CNS neuroscience & therapeutics, 17(5), 462, 10.1111/j.1755-5949.2010.00170.x · DOI
  24. P Dharmshaktu, 2012, Efficacy of antidepressants as analgesics: a review, Journal of clinical pharmacology, 52(1), 6, 10.1177/0091270010394852 · DOI · Paper page
  25. P Shannon, 2003, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome research, 13(11), 2498, 10.1101/gr.1239303 · DOI · Paper page
  26. R Edgar, 2002, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository, Nucleic acids research, 30(1), 207, 10.1093/nar/30.1.207 · DOI · Paper page
  27. N Speer, 2005, Spectral Clustering Gene Ontology Terms to Group Genes by Function, Lecture Notes in Bioinformatics (LNBI), 3692, 1
  28. J Béïque, 2000, Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat, Neuropharmacology, 39(10), 1800, 10.1016/S0028-3908(00)00017-4 · DOI
  29. A Becher, 1999, The synaptophysin-synaptobrevin complex: a hallmark of synaptic vesicle maturation, J Neurosci, 19(6), 1922, 10.1523/JNEUROSCI.19-06-01922.1999 · DOI · Paper page
  30. M Yamada, 2002, Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex, Pharmacogenomics, 2(6), 377, 10.1038/sj.tpj.6500135 · DOI
  31. C Lopez de Lara, 2010, Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses, Int J Neuropsychopharmacol, 13, 1397, 10.1017/S1461145710000714 · DOI · Paper page
  32. M Seimandi, 2013, Calcineurin Interacts with the Serotonin Transporter C-Terminus to Modulate Its Plasma Membrane Expression and Serotonin Uptake, J Neurosci, 33(41), 16189, 10.1523/JNEUROSCI.0076-13.2013 · DOI
  33. C Zhao, 2001, Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta, Cell, 105(5), 587, 10.1016/S0092-8674(01)00363-4 · DOI · Paper page
  34. DC Charalambous, 2013, KIF1Bβ transports dendritically localized mRNPs in neurons and is recruited to synapses in an activity-dependent manner, Cell Mol Life Sci, 70(2), 335, 10.1007/s00018-012-1108-0 · DOI
  35. KN Karle, 2012, Axonal transport deficit in a KIF5A (-/-) mouse model, Neurogenetics, 13(2), 169, 10.1007/s10048-012-0324-y · DOI
  36. M Watanabe, 2005, Myosin-Va regulates exocytosis through the submicromolar Ca2+-dependent binding of syntaxin-1A, Mol Biol Cell, (10), 4519, 10.1091/mbc.E05-03-0252 · DOI · Paper page
  37. exocytosis Söllner TH Regulated, 2003, Mol, Membr Biol, 20, 209
  38. C Li, 1994, Synaptic targeting of rabphilin-3A, a synaptic vesicle Ca2+/phospholipid-binding protein, depends on rab3A/3C, Neuron, (4), 885, 10.1016/0896-6273(94)90254-2 · DOI · Paper page
  39. G Lonart, 2002, RIM1: an edge for presynaptic plasticity, Trends Neurosci, (7), 329, 10.1016/S0166-2236(02)02193-8 · DOI
  40. JP Silva, 2011, Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signalling capabilities, Proc Natl Acad Sci USA, 108(29), 12113, 10.1073/pnas.1019434108 · DOI · Paper page
  41. G Maccarrone, 2013, Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters, J Psychiatr Res, 47(11), 1572, 10.1016/j.jpsychires.2013.07.021 · DOI
  42. T Yagi, 2013, Genetic basis of neuronal individuality in the mammalian brain, J Neurogenet, (3), 97, 10.3109/01677063.2013.801969 · DOI · Paper page
  43. L Mandelli, 2013, Gene environment interaction studies in depression and suicidal behavior: An update, Neurosci Biobehav Rev 37(10 Pt, 1), 2375, 10.1016/j.neubiorev.2013.07.011 · DOI · Paper page
  44. M Mayer, 2010, Expression of two type II cadherins, Cdh12 and Cdh22 in the developing and adult mouse brain, Gene Expr Patterns, 7–8, 351, 10.1016/j.gep.2010.08.002 · DOI
  45. V Castellani, 1998, Dual action of a ligand for Eph receptor tyrosine kinases on specific populations of axons during the development of cortical circuits, J Neurosci, 18(12), 4663, 10.1523/JNEUROSCI.18-12-04663.1998 · DOI
  46. A Gely-Pernot, 2012, An endogenous vitamin K-dependent mechanism regulates cell proliferation in the brain subventricular stem cell niche, Stem Cells, 4, 719, 10.1002/stem.1045 · DOI
  47. M Denaxa, 2001, The adhesion molecule TAG-1 mediates the migration of cortical interneurons from the ganglionic eminence along the corticofugal fiber system, Development, 128(22), 4635, 10.1242/dev.128.22.4635 · DOI · Paper page
  48. QH Ma, 2008, A TAG1-APP signaling pathway through Fe65 negatively modulates neurogenesis, Nat Cell Biol, 3, 283
  49. Y Feng, 2008, Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders(, Am J Psychiatry, 165, 610, 10.1176/appi.ajp.2007.07050805 · DOI
  50. DR Rosenberg, 2004, Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls, Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1146, 10.1097/01.chi.0000132812.44664.2d · DOI · Paper page
  51. W Myung, 2012, Genetic association study of individual symptoms in depression, Psychiatry Res, 198(3), 400, 10.1016/j.psychres.2011.12.037 · DOI
  52. R Martinez-Turrillas, 2002, Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus, Neuropharmacology, 43, 1230, 10.1016/S0028-3908(02)00299-X · DOI
  53. A Barbon, 2006, Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs, Biological Psychiatry, 59, 713, 10.1016/j.biopsych.2005.10.018 · DOI
  54. N Aragam, 2013, TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample, J Mol Neurosci, 50, 250, 10.1007/s12031-012-9931-1 · DOI
  55. B Sutor, 1989, Long-term potentiation in frontal cortex: role of NMDA-modulated polysynaptic excitatory pathways, Neurosci Lett, 97(1–2), 111, 10.1016/0304-3940(89)90148-1 · DOI
  56. MP Cunha, 2013, The antidepressant-like effect of physical activity on a voluntary running wheel, Med Sci Sports Exerc, 45(5), 851, 10.1249/MSS.0b013e31827b23e6 · DOI
  57. AL Frederick, 2012, Neurobehavioral phenotyping of G(αq) knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair, Front Behav Neurosci, 6, 29, 10.3389/fnbeh.2012.00029 · DOI
  58. E Nowakowska, 2003, Comparison of behavioural effects of venlafaxine and imipramine in rats, Arzneimittelforschung, 53(4), 237
  59. T Matozaki, 2009, Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway, Trends Cell Biol, 2, 72, 10.1016/j.tcb.2008.12.001 · DOI · Paper page
  60. H Ohnishi, 2010, Stress-evoked tyrosine phosphorylation of signal regulatory protein α regulates behavioral immobility in the forced swim test, J Neurosci, 31, 10472, 10.1523/JNEUROSCI.0257-10.2010 · DOI
  61. A Fragkouli, 2012, Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9, J. Neurochem, 121, 239, 10.1111/j.1471-4159.2011.07637.x · DOI · Paper page
  62. C Adori, 2006, Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns, J Comp Neurol, 497(2), 251, 10.1002/cne.20994 · DOI
  63. GS Zubenko, 1984, Mood elevating effect of captopril in depressed patients. Am, J Psychiatry, 141, 110
  64. MS Kramer, 1998, Distinct mechanism for antidepressant activity by blockade of central substance P receptors, Science, 281, 1640, 10.1126/science.281.5383.1640 · DOI · Paper page
  65. C Preuschhof, 2010, KIBRA and CLSTN2 polymorphisms exert interactive effects on human episodic memory, Neuropsychologia, 48(2), 402, 10.1016/j.neuropsychologia.2009.09.031 · DOI
  66. MM Shah, 2012, HCN1 channels: a new therapeutic target for depressive disorders?, Sci Signal, 5(244), 44
  67. MF Nolan, 2003, The hyperpolarization-activated HCN1 channel is important for motor learning and neuronal integration by cerebellar Purkinje cells, Cell, 115, 551, 10.1016/S0092-8674(03)00884-5 · DOI · Paper page
  68. MA Gruden, 2013, Distinct functional brain regional integration of Casp3, Ascl1 and S100a6 gene expression in spatial memory, Behav Brain Res, 252, 230, 10.1016/j.bbr.2013.06.024 · DOI
  69. EJ Kim, 2007, In vivo analysis of Ascl1 defined progenitors reveals distinct developmental dynamics during adult neurogenesis and gliogenesis, J Neurosci, 27(47), 12764, 10.1523/JNEUROSCI.3178-07.2007 · DOI · Paper page
  70. D Ben-Shachar, 2008, Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One, 3(11), e3676
  71. M Manczak, 2013, Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies, J Alzheimers Dis, 37(4), 679, 10.3233/JAD-130761 · DOI · Paper page
  72. J Goemaere, 2012, Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders, J Comp Neurol, 520(2), 258, 10.1002/cne.22689 · DOI
  73. HW Kim, 2010, Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients, Neurobiol Dis, 37(3), 596, 10.1016/j.nbd.2009.11.010 · DOI · Paper page
  74. Y Wang, 2011, Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium, Hum Psychopharmacol, 2, 95, 10.1002/hup.1177 · DOI
  75. LE Egede, 2013, Effect of comorbid depression on quality of life in adults with Type 2 diabetes, Expert Rev Pharmacoecon Outcomes Res, 13(1), 83, 10.1586/erp.12.86 · DOI · Paper page
  76. CC Lee, 2005, Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signalling pathway, J Biol Chem, 280(18), 18543
  77. A Marucci, 2009, The role of HSP70 on ENPP1 expression and insulin-receptor activation, J Mol Med (Berl), 87(2), 139, 10.1007/s00109-008-0429-9 · DOI
  78. Y Benomar, 2006, Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism, Endocrinology, 147(5), 2550, 10.1210/en.2005-1464 · DOI · Paper page
  79. AM Vincent, 2004, Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death, Diabetes, 53(3), 726, 10.2337/diabetes.53.3.726 · DOI · Paper page
  80. MJ During, 2003, Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med, 9(9), 1173
  81. H KroezeY, Zhou, 2012, The genetics of selective serotonin reuptake inhibitors. Pharmacol Ther, Dec, 136(3), 375
  82. ES Vizi, 2013, Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res Bull, Apr, 93, 32
  83. E Kirilly, 2012, CB1 receptor antagonists: new discoveries leading to new perspectives, Acta Physiol (Oxf), 205(1), 41, 10.1111/j.1748-1716.2011.02402.x · DOI · Paper page
  84. M Umehara, 2013, Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats, Eur J Pharmacol Feb 28, 702(1–3), 250, 10.1016/j.ejphar.2013.01.033 · DOI
  85. HA Mitchell, 2006, The effects of norepinephrine transporter inactivation on locomotor activity in mice, Biol Psychiatry, 60(10), 1046, 10.1016/j.biopsych.2006.03.057 · DOI

Cited by

See all 61

Metadata

Authors
Tamási, V., Petschner, P., Adori, C., Kirilly, E., Ando, R. D., Tothfalusi, L., Juhasz, G., & Bagdy, G.
Venue
PLoS ONE
Published
2014-11-25
Volume
9
Issue
11
Pages
e113662
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2059676567
Cited by
61
References
19
FWCI
2.16
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes. https://app.cochat.ai/papers/10.1371/journal.pone.0113662
The paper
Tamási, V., Petschner, P., Adori, C., Kirilly, E., Ando, R. D., Tothfalusi, L., Juhasz, G., & Bagdy, G. (2014). Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes. PLoS ONE. https://doi.org/10.1371/journal.pone.0113662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.